Adaptive Biotechnologies (ADPT) Financials: Revenue & Earnings

ADPT price $28.42 +0.76 +2.74%

Ticker
ADPT
Price
$28.42
Change
+0.76 +2.74%
Market cap ?
$4.54B
P/E ?
-70.48
Forward P/E ?
2680.57
Dividend yield ?
0.00%
Beta ?
2.10
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
56
Value
50
Quality
37
Growth
82

Stocklytics score rationale: value 50, quality 37, growth 82.

Financials

201720182019202020212022202320242025
38448000556630008507100098382000154344000185308000170276000178957000276976000

Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core…

Fair value

ADPT fair value Not meaningful. Price $28.42.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare ADPT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.09—71.57M
2026-07-29-0.25-0.1371.55M65.44M
2026-05-05-0.13-0.1670.90M61.03M
2026-02-05-0.09-0.1971.68M60.89M
2025-11-060.06-0.1893.97M64.63M
2025-08-05-0.17-0.2458.88M49.40M
2025-05-05-0.20-0.3452.44M42.68M
2025-02-12-0.23-0.2747.46M46.05M
2024-11-07-0.22-0.2946.44M40.24M
2024-08-01-0.31-0.3343.19M38.63M
2024-05-07-0.33-0.3441.87M38.78M
2024-02-13-0.48-0.3345.78M48.45M
2023-11-09-0.48-0.3337.92M42.96M
2023-08-02-0.33-0.3548.93M44.87M
2023-05-03-0.40-0.3837.65M36.81M
2023-02-14-0.28-0.3555.20M54.72M
2022-11-03-0.32-0.3847.83M47.81M
2022-08-03-0.37-0.4343.66M41.81M
2022-05-04-0.44-0.4638.62M37.77M
2022-02-15-0.43-0.4537.93M36.37M
2021-11-03-0.40-0.4239.47M37.07M
2021-08-04-0.35-0.4338.51M31.26M
2021-05-05-0.29-0.4138.44M27.75M
2021-02-24-0.33-0.2930.18M26.02M
2020-11-10-0.27-0.2826.30M27.24M
2020-08-10-0.26-0.2820.99M22.60M
2020-05-12-0.25-0.2020.91M16.73M
2020-02-26-0.17-0.2024.21M28.48M
2019-11-12-0.11-0.2426.06M56.85M
2019-08-13-1.23-0.1422.14M135.20M
2019-06-27-0.15—12.67M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-26RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-26RUBINSTEIN JULIESell8.50K$25.94220.57K
2026-10-26RUBINSTEIN JULIESell3.38K$26.3088.84K
2026-10-26RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-23RUBINSTEIN JULIESell4.50K$24.50110.25K
2026-10-23RUBINSTEIN JULIESell7.38K$25.28186.59K
2026-10-23RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-22RUBINSTEIN JULIESell10.18K$24.38248.21K
2026-10-22RUBINSTEIN JULIESell1.70K$25.2942.99K
2026-10-22RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-21RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-21RUBINSTEIN JULIESell6.00K$25.25151.47K
2026-10-21RUBINSTEIN JULIESell5.88K$25.57150.40K
2026-10-21RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-20RUBINSTEIN JULIESell11.78K$24.53288.99K
2026-10-20RUBINSTEIN JULIESell100$24.852.48K
2026-10-20RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-19RUBINSTEIN JULIESell11.88K$24.05285.74K
2026-10-19RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-16RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-16RUBINSTEIN JULIESell11.58K$24.21280.38K
2026-10-16RUBINSTEIN JULIESell300$25.457.63K
2026-10-16RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-15RUBINSTEIN JULIESell11.88K$25.61304.27K
2026-10-15RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-14RUBINSTEIN JULIESell6.78K$25.57173.39K
2026-10-14RUBINSTEIN JULIESell5.10K$25.82131.68K
2026-10-14RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-13RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-13RUBINSTEIN JULIESell11.88K$25.50302.97K
2026-10-13RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-12RUBINSTEIN JULIESell9.18K$25.35232.74K
2026-10-12RUBINSTEIN JULIESell2.70K$26.0770.39K
2026-10-12RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-09RUBINSTEIN JULIESell11.88K$26.41313.78K
2026-10-09RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-08RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-08RUBINSTEIN JULIESell11.88K$25.66304.87K
2026-10-08RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-07RUBINSTEIN JULIESell11.88K$26.40313.66K
2026-10-07RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-06RUBINSTEIN JULIESell9.38K$27.36256.66K
2026-10-06RUBINSTEIN JULIESell1.10K$28.2131.03K
2026-10-06RUBINSTEIN JULIESell901$29.7126.77K
2026-10-06RUBINSTEIN JULIESell499$30.5315.23K
2026-10-06RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-06BOBULSKY SUSANSell6.44K$30.00193.32K
2026-10-05RUBINSTEIN JULIEBuy11.88K$12.14144.24K
2026-10-05RUBINSTEIN JULIESell6.70K$28.82193.07K
2026-10-05RUBINSTEIN JULIESell5.18K$29.67153.75K
2026-10-05RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-02RUBINSTEIN JULIESell11.88K$28.13334.21K
2026-10-02RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-01RUBINSTEIN JULIESell6.08K$27.57167.65K
2026-10-01RUBINSTEIN JULIESell5.80K$28.56165.65K
2026-10-01RUBINSTEIN JULIESell11.88K$12.14144.24K
2026-10-01LO FRANCISBuy9.38K$8.1276.14K
2026-10-01LO FRANCISSell8.09K$27.52222.75K
2026-10-01LO FRANCISBuy9.38K$3.9937.41K
2026-10-01LO FRANCISBuy8.04K$8.4668.00K
2026-10-01LO FRANCISSell18.70K$28.61534.95K
2026-10-01LO FRANCISSell9.38K$8.1276.14K
2026-10-01LO FRANCISSell9.38K$3.9937.41K
2026-10-01LO FRANCISSell8.04K$8.4668.00K
2026-09-16LO FRANCISBuy23.44K$8.12190.35K
2026-09-16LO FRANCISBuy15.63K$3.9962.36K
2026-09-16LO FRANCISBuy13.40K$8.46113.35K
2026-09-16LO FRANCISBuy53.09K$12.14644.52K
2026-09-16LO FRANCISSell107.54K$28.023.01M
2026-09-16LO FRANCISSell7.87K$28.57224.82K
2026-09-16LO FRANCISSell23.44K$8.12190.35K
2026-09-16LO FRANCISSell53.09K$12.14644.52K
2026-09-16LO FRANCISSell15.63K$3.9962.36K
2026-09-16LO FRANCISSell13.40K$8.46113.35K
2026-09-15BOBULSKY SUSANSell1.20K$27.0032.27K
2026-08-31OWEN KATEY EINTERZSell12.54K——
2026-08-26OWEN KATEY EINTERZSell9.62K$26.00249.99K
2026-08-18HERSHBERG ROBERTBuy15.00K$6.3294.80K
2026-08-18HERSHBERG ROBERTSell15.00K$24.39365.85K
2026-08-18HERSHBERG ROBERTSell15.66K$24.41382.36K
2026-08-18HERSHBERG ROBERTSell15.00K$6.3294.80K
2026-08-18ROBINS CHAD MBuy278.68K$6.551.83M
2026-08-18ROBINS CHAD MSell278.47K$24.486.82M
2026-08-18ROBINS CHAD MSell204$25.145.13K
2026-08-18ROBINS CHAD MSell278.68K$6.551.83M
2026-08-17ROBINS CHAD MBuy321.32K$6.552.10M
2026-08-17ROBINS CHAD MSell318.80K$25.088.00M
2026-08-17ROBINS CHAD MSell2.52K$25.5764.56K
2026-08-17ROBINS CHAD MSell321.32K$6.552.10M
2026-08-17NEUPERT PETER MBuy15.00K$6.3294.80K
2026-08-17NEUPERT PETER MSell15.00K$25.23378.45K
2026-08-17NEUPERT PETER MSell40.00K$25.101.00M
2026-08-17NEUPERT PETER MSell69.69K$25.161.75M
2026-08-17NEUPERT PETER MSell15.00K$6.3294.80K
2026-08-10BOBULSKY SUSANSell3.00K$25.0075.00K
2026-07-30BOBULSKY SUSANSell1.30K$24.0031.18K
2026-07-21ROBINS HARLAN SBuy284.80K$6.551.87M
2026-07-21ROBINS HARLAN SSell278.70K$21.726.05M
2026-07-21ROBINS HARLAN SSell213.70K$22.124.73M
2026-07-21ROBINS HARLAN SSell284.80K$6.551.87M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 310, holders +8 vs prior quarter. Ownership 398.30%.

HolderSharesChangeChange %Value
VIKING GLOBAL INVESTORS LP29.99M00.00%643.37M
BLACKROCK, INC.15.14M1.84M+13.80%324.73M
VANGUARD CAPITAL MANAGEMENT LLC6.40M309.44K+5.08%137.36M
WELLINGTON MANAGEMENT GROUP LLP5.91M2.05M+53.25%126.80M
VANGUARD PORTFOLIO MANAGEMENT LLC5.48M984.76K+21.93%117.47M
D. E. SHAW & CO., INC.4.63M2.66M+135.34%99.22M
WESTFIELD CAPITAL MANAGEMENT CO LP4.27M-1.17M-21.50%91.54M
GEODE CAPITAL MANAGEMENT, LLC3.64M5.78K+0.16%78.13M
STATE STREET CORP3.46M231.14K+7.16%74.18M
INVESCO LTD.3.09M-1.36M-30.47%66.37M
GOLDMAN SACHS GROUP INC2.98M-257.85K-7.95%64.01M
UBS GROUP AG2.86M2.64M+1166.50%61.39M
PRICE T ROWE ASSOCIATES INC /MD/2.67M1.10M+70.18%57.17M
DRIEHAUS CAPITAL MANAGEMENT LLC2.53M777.10K+44.39%54.22M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.52M529.42K+26.53%54.15M
LORD, ABBETT & CO. LLC2.47M-1.06M-30.01%53.09M
NUVEEN, LLC2.37M1.06M+81.43%50.75M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.2.18M-505.75K-18.81%46.81M
FRED ALGER MANAGEMENT, LLC2.09M29.14K+1.41%44.88M
ARK INVESTMENT MANAGEMENT LLC2.09M-2.66K-0.13%44.84M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.97M1.81M+1149.10%42.28M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.1.89M8.01K+0.43%40.52M
ARISTOTLE ATLANTIC PARTNERS, LLC1.84M124.17K+7.24%39.44M
TORONTO DOMINION BANK1.80M1.80MNew38.61M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.1.78M860.37K+93.59%38.17M

Earnings and financials

Adaptive Biotechnologies Corporation (ADPT) trades at $28.42, with a market cap of $4.54B and a trailing P/E of -70.48. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
38448000556630008507100098382000154344000185308000170276000178957000276976000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Adaptive Biotechnologies (ADPT) Financials: Revenue & Earnings

ADPT$28.42+0.76 +2.74%

$4.54B

Market Cap

-70.48

P/E

2680.57

Forward P/E

56

Score

Price History